Related contentthis may interest you
Posted on 13.10.2026
From assessment to access: navigating the EU’s new HTA framework
In early October 2026, the European Commission adopted its first decision to select two medical devices for joint clinical assessment under the EU Health Technology Assessment (HTA). What does this mean for medtech innovators? Tune into the latest episode of MedTech ON AIR, recorded live from our booth at The MedTech Forum 2026, where Frédérique […]
Posted on 22.09.2026
Living healthier for longer: the role of medical technology in Europe’s longevity challenge
By Xavier Bertrand, Senior Vice President and President EMEA, Boston Scientific
Posted on 09.09.2026
The hidden economic burden of wounds: why Europe cannot afford to ignore wound care
By Luella Trickett, Executive Director, Medical Devices, Value and Access, ABHI

